The agreement makes M-Vu CAD immediately available through Siemens Healthcare’s US distribution network.

VuCOMP president and CEO Jeff Wehnes noted the company is pleased to be working with Siemens to offer its M-Vu CAD as part of Siemens’ innovative portfolio of digital mammography solutions.

"This represents another step forward in our singular goal of helping radiologists find cancer sooner by providing them with advanced cancer-detecting tools," Wehnes added.

M-Vu CAD uses advanced computer vision algorithms to identify areas in mammograms consistent with breast cancer, and is the first product to meet the US Food and Drug Administration-recommended reader study standard for proving the effectiveness of mammography CAD.